According to GWAS studies, SLCs including SLC2A9, SLC16A9, SLC17A1, SLC17A3, SLC22A11, and SLC22A12 were risk loci for gout (Dehghan et al., 2008; Kolz et al., 2009; Flynn et al., 2013). This evidence concerns the gene SLC16A9 and gout.